Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Post by rome1on Oct 29, 2010 12:41pm
512 Views
Post# 17631044

We shall see

We shall see
They are going to address that "letter of intent" sooner or later and we shall see what happens. Right now it is wrapped up in "confidentiality".

You honestly think it is us little penny flippers are responsible for 10 million plus in volume today.....what is the combined volume with the Alpha exchange?

There will be more buying in the last hour.....those who purchased this morning at .18 will average down at .16 if they can.....some people are well aware of the pending news....a week or two...whatever.

Of course the price will go up and down....but the only real question is if you want to be in or out until real news comes out.

I can assure you the company is not awestruck by .16 cents a share....

rome.

Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse